---
title: "DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295007946.md"
description: "Q2 2026 revenue fell 48% year-over-year to $20 million, with a net loss from continuing operations of $(57) million and Adjusted EBITDA of $(36) million. Major government contracts were secured for autonomous labs, and full-year cash burn is expected between $(150) million and $(125) million.Original document: Ginkgo Bioworks Holdings, Inc. [DNA] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T20:13:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295007946.md)
  - [en](https://longbridge.com/en/news/295007946.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295007946.md)
generator: "portal-rs"
---

# DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured

Q2 2026 revenue fell 48% year-over-year to $20 million, with a net loss from continuing operations of $(57) million and Adjusted EBITDA of $(36) million. Major government contracts were secured for autonomous labs, and full-year cash burn is expected between $(150) million and $(125) million.

Original document: Ginkgo Bioworks Holdings, Inc. \[DNA\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)

## Related News & Research

- [DNA regained Nasdaq equity compliance but faces one-year mandatory monitor](https://longbridge.com/en/news/297562517.md)
- [Ginkgo Bioworks joins Waterfall Scientific-led ARPA-H consortium to build autonomous RNA drug manufacturing system](https://longbridge.com/en/news/298590935.md)
- [11:49 ETGroundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening Results](https://longbridge.com/en/news/298343980.md)
- [AI Will Help Find A Cure For Cancer, Claims UK Chip Giant Boss](https://longbridge.com/en/news/298299435.md)
- [FREEM: Expansion into manufacturing services targets a 20x larger market and EBITDA positivity by 2028](https://longbridge.com/en/news/298413697.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**